fear of hypoglycaemia and gain in body weight are barriers for initiation of insulin therapy . modern insulin analogues are a convenient new approach or tool to glycaemic control , associated with low number of hypoglycaemia and favourable weight change . a1chieve , a multinational , 24-week , non - interventional study , assessed the safety and effectiveness of insulin analogues in people with t2 dm ( n = 66,726 ) in routine clinical care . this short communication presents the results for patients enrolled in biphasic insulin aspart sub group from libya . please refer to editorial titled : the a1chieve study : mapping the ibn battuta trail . the study was started with an aim to collect data on all the insulin analogue viz insulin detemir , biphasic insulin aspart and insulin aspart . however , due to ongoing revolution , the complete data could not be collected . here the majority of patients ( 189 ) were started on or were switched to biphasic insulin aspart . other groups were insulin detemir ( n = 58 ) , basal + insulin aspart ( n = 44 ) and other insulin combinations ( n = 25 ) . being the biggest treatment group , this communication describes the results for patients treated with insulin therapy before and then switched to biphasic insulin aspart . overall demographic data 179 patients started on biphasic insulin aspart  ogld , and all the patients were on insulin therapy prior to the study . after 24 weeks of switching to biphasic insulin aspart , hypoglycaemic events reduced from 7.2 events / patient - year to 3.7 events / patient - year [ tables 2 and 3 ] . all parameters of glycaemic control improved from baseline to study end [ table 4 ] . overall efficacy data 179 patients started on biphasic insulin aspart  ogld , and all the patients were on insulin therapy prior to the study . after 24 weeks of switching to biphasic insulin aspart , hypoglycaemic events reduced from 7.2 events / patient - year to 3.7 events / patient - year [ tables 2 and 3 ] . all parameters of glycaemic control improved from baseline to study end [ table 4 ] . our study reports improved glycaemic control following 24 weeks of treatment with biphasic insulin aspart with or without ogld . hypoglycemic events decreased from baseline and sadrs did not occur in any of the study patients . though the findings are limited by number of patients , still the trend indicates that biphasic insulin aspart can be considered effective and possess a safe profile for treating type 2 diabetes in libya .